Elixinol Wellness (ELLXF) Ratios
Elixinol Wellness Ratios
ELLXF's free cash flow for Q2 2026 was $-733.00K. For the 2026 fiscal year, ELLXF's free cash flow was decreased by $-21.00K and operating cash flow was $-712.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.86 | 1.44 | 1.64 | 2.71 | 4.15 |
| Quick Ratio | 0.46 | 0.66 | 0.90 | 2.20 | 3.69 |
| Cash Ratio | 0.21 | 0.22 | 0.14 | 0.83 | 2.68 |
| Solvency Ratio | -0.54 | -0.08 | -1.32 | -2.28 | -2.48 |
| Operating Cash Flow Ratio | -0.48 | -0.70 | -0.55 | -2.37 | -2.98 |
| Short-Term Operating Cash Flow Coverage | -0.99 | -3.11 | -5.25 | -25.48 | -32.88 |
| Net Current Asset Value | $ -2.81M | $ -1.25M | $ 2.93M | $ 4.99M | $ 13.33M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.11 | 0.11 | 0.14 | 0.11 |
| Debt-to-Equity Ratio | 0.50 | 0.19 | 0.20 | 0.20 | 0.14 |
| Debt-to-Capital Ratio | 0.33 | 0.16 | 0.16 | 0.17 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.05 | 0.03 | 0.03 | 0.01 |
| Financial Leverage Ratio | 2.14 | 1.84 | 1.81 | 1.47 | 1.33 |
| Debt Service Coverage Ratio | -0.95 | -0.32 | -10.88 | -23.74 | -29.70 |
| Interest Coverage Ratio | -10.20 | -16.36 | -63.69 | -140.87 | -169.66 |
| Debt to Market Cap | 1.46 | 0.28 | 0.04 | 0.04 | 0.05 |
| Interest Debt Per Share | 0.02 | 0.01 | 0.00 | 0.00 | 0.01 |
| Net Debt to EBITDA | -0.56 | -0.21 | -0.08 | 0.11 | 0.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 4.85% | 35.82% | -21.82% | -46.29% | -66.98% |
| EBIT Margin | -32.10% | -33.78% | -89.53% | -141.77% | -182.03% |
| EBITDA Margin | -26.50% | -26.81% | -82.31% | -131.55% | -166.07% |
| Operating Profit Margin | -32.10% | -23.19% | -77.80% | -141.77% | -167.16% |
| Pretax Profit Margin | -38.94% | -35.51% | -90.75% | -149.81% | -183.02% |
| Net Profit Margin | -35.48% | -11.51% | -90.78% | -149.84% | -182.32% |
| Continuous Operations Profit Margin | -35.48% | -11.51% | -90.78% | -149.84% | -182.32% |
| Net Income Per EBT | 91.14% | 32.42% | 100.04% | 100.02% | 99.62% |
| EBT Per EBIT | 121.28% | 153.14% | 116.65% | 105.67% | 109.49% |
| Return on Assets (ROA) | -34.45% | -9.33% | -64.10% | -78.39% | -67.21% |
| Return on Equity (ROE) | -73.81% | -17.18% | -116.17% | -115.43% | -89.24% |
| Return on Capital Employed (ROCE) | -53.38% | -25.76% | -95.69% | -99.57% | -75.71% |
| Return on Invested Capital (ROIC) | -35.63% | -7.62% | -82.55% | -90.42% | -71.35% |
| Return on Tangible Assets | -50.86% | -14.03% | -79.74% | -79.28% | -68.46% |
| Earnings Yield | -238.52% | -29.32% | -38.54% | -81.29% | -131.44% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.01 | 9.30 | 4.85 | 9.83 | 14.87 |
| Payables Turnover | 9.70 | 5.28 | 5.72 | 9.59 | 11.45 |
| Inventory Turnover | 5.55 | 2.47 | 2.75 | 5.93 | 7.08 |
| Fixed Asset Turnover | 12.47 | 10.49 | 6.98 | 6.34 | 3.76 |
| Asset Turnover | 0.97 | 0.81 | 0.71 | 0.52 | 0.37 |
| Working Capital Turnover Ratio | 24.84 | 5.56 | 1.83 | 0.68 | 0.41 |
| Cash Conversion Cycle | 56.21 | 118.07 | 144.30 | 60.63 | 44.19 |
| Days of Sales Outstanding | 28.05 | 39.24 | 75.30 | 37.15 | 24.55 |
| Days of Inventory Outstanding | 65.78 | 147.92 | 132.77 | 61.53 | 51.52 |
| Days of Payables Outstanding | 37.62 | 69.09 | 63.77 | 38.05 | 31.88 |
| Operating Cycle | 93.83 | 187.16 | 208.07 | 98.68 | 76.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.02 | -0.03 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.02 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -49.45 | -57.82 | -162.24 | -679.33 | -48.19 |
| Capital Expenditure Coverage Ratio | -49.45 | -57.82 | -162.24 | -679.33 | -48.19 |
| Operating Cash Flow Coverage Ratio | -0.86 | -1.79 | -2.19 | -4.44 | -5.18 |
| Operating Cash Flow to Sales Ratio | -0.21 | -0.23 | -0.33 | -1.16 | -1.51 |
| Free Cash Flow Yield | -142.20% | -60.09% | -14.25% | -62.78% | -110.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.42 | -3.42 | -2.59 | -1.23 | -0.76 |
| Price-to-Sales (P/S) Ratio | 0.15 | 0.39 | 2.36 | 1.84 | 1.39 |
| Price-to-Book (P/B) Ratio | 0.31 | 0.59 | 3.01 | 1.42 | 0.68 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.70 | -1.66 | -7.02 | -1.59 | -0.90 |
| Price-to-Operating Cash Flow Ratio | -0.72 | -1.69 | -7.06 | -1.60 | -0.92 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.35 | 0.05 | 0.03 | 0.01 |
| Enterprise Value Multiple | -1.13 | -1.68 | -2.94 | -1.29 | -0.19 |
| Enterprise Value | 4.63M | 6.73M | 20.03M | 11.98M | 3.02M |
| EV to EBITDA | -1.13 | -1.68 | -2.94 | -1.29 | -0.19 |
| EV to Sales | 0.30 | 0.45 | 2.42 | 1.70 | 0.32 |
| EV to Free Cash Flow | -1.41 | -1.91 | -7.22 | -1.47 | -0.21 |
| EV to Operating Cash Flow | -1.44 | -1.94 | -7.26 | -1.47 | -0.21 |
| Tangible Book Value Per Share | 0.01 | 0.02 | 0.01 | 0.02 | 0.05 |
| Shareholders’ Equity Per Share | 0.03 | 0.06 | 0.01 | 0.02 | 0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 0.68 | -0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.06 | 0.10 | 0.01 | 0.02 | 0.02 |
| Net Income Per Share | -0.02 | -0.01 | -0.01 | -0.03 | -0.04 |
| Tax Burden | 0.91 | 0.32 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.21 | 1.05 | 1.01 | 1.06 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.56 | 0.53 | 0.75 | 0.63 | 1.39 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.08 | 0.03 | 0.02 |
| Income Quality | 0.58 | 2.01 | 0.37 | 0.77 | 0.83 |
Currency in AUD